Literature DB >> 15147807

Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery.

Yoshinori Onuki1, Mariko Morishita, Kozo Takayama.   

Abstract

Formulation optimization of the water-in-oil-in-water multiple emulsion incorporating insulin was performed based on statistical methods such as the orthogonal experimental design and the response surface evaluation. As model formulations, 16 types of emulsions were prepared according to the orthogonal experimental design. To optimize the formulation, the influence of causal factors such as amounts of gelatin, insulin, oleic acid (OA) and the volume ratio of the outer aqueous phase to total and agitation time of the second emulsification process on individual characteristics of the emulsion, such as inner droplet size, viscosity, stability and pharmacological effect, was evaluated first. Based on the analysis of ANOVA, it was concluded that the droplet size of the emulsion was influenced by the volume ratio of the outer aqueous phase significantly. The viscosity of the emulsion was affected by these causal factors and their interactions; however, the most predominant contribution of all causal factors was the volume ratio of the outer aqueous phase. Similarly, one of the most important characteristics in the design of the formulation, stability, was affected by the causal factors. With regard to the hypoglycemic effect, the most influential factor was the content of OA in the emulsion. By means of a novel optimization technique involving a multivariate spline interpolation (MSI), formulation optimization was performed with respect to pharmacological effect and stability, and the optimum formulation with a desirable pharmacological effect and high stability was successfully estimated. Coyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147807     DOI: 10.1016/j.jconrel.2004.03.010

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  7 in total

1.  Formulation optimization of an indomethacin-containing photocrosslinked polyacrylic acid hydrogel as an anti-inflammatory patch.

Authors:  Masato Nishikawa; Yoshinori Onuki; Koichi Isowa; Kozo Takayama
Journal:  AAPS PharmSciTech       Date:  2008-09-18       Impact factor: 3.246

2.  Novel route of insulin delivery using an implant-mediated drug delivery system.

Authors:  Young-Seok Park
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

3.  Liposomes in double-emulsion globules.

Authors:  Qing Wang; Grace Tan; Louise B Lawson; Vijay T John; Kyriakos D Papadopoulos
Journal:  Langmuir       Date:  2010-03-02       Impact factor: 3.882

4.  Key functions in polymer carriers for intestinal absorption of insulin.

Authors:  Koji Nakamura; Mariko Morishita; Junpei Ehara; Yoshinori Onuki; Tetsuo Yamagata; Noriyasu Kamei; Anthony M Lowman; Nicholaos A Peppas; Kozo Takayma
Journal:  Int J Pharm       Date:  2007-11-09       Impact factor: 5.875

5.  Injectable supramolecular hydrogel from insulin-loaded triblock PCL-PEG-PCL copolymer and γ-cyclodextrin with sustained-release property.

Authors:  Elham Khodaverdi; Zinat Heidari; Sayyed A Sajadi Tabassi; Mohsen Tafaghodi; Mona Alibolandi; Farnaz Sadat Mirzazadeh Tekie; Bahman Khameneh; Farzin Hadizadeh
Journal:  AAPS PharmSciTech       Date:  2014-09-16       Impact factor: 3.246

6.  Ultrarapid Inflammation of the Olfactory Bulb After Spinal Cord Injury: Protective Effects of the Granulocyte Colony-Stimulating Factor on Early Neurodegeneration in the Brain.

Authors:  Muh-Shi Lin; I-Hsiang Chiu; Chai-Ching Lin
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

7.  In vivo evaluation of a conjugated poly(lactide-ethylene glycol) nanoparticle depot formulation for prolonged insulin delivery in the diabetic rabbit model.

Authors:  Lomas Tomar; Charu Tyagi; Manoj Kumar; Pradeep Kumar; Harpal Singh; Yahya E Choonara; Viness Pillay
Journal:  Int J Nanomedicine       Date:  2013-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.